Abstract
In 2020, 5% sofpironium bromide (ECCLOCK(R)) gel (hereinafter referred to as sofpironium) was approved in Japan for the topical treatment of primary a......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
